Omicron breakthrough infection in a kidney-transplant patient given pre-exposition casirivimab and imdevimab monoclonal antibodies.

Kamar, Nassim; Gouin, Anna; Izopet, Jacques

Kamar, Nassim; Gouin, Anna; Izopet, Jacques.

Kamar N; Department of Nephrology and Organs Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
Gouin A; INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
Izopet J; Paul Sabatier University, Toulouse, France.

Transpl Infect Dis ; 24(2): e13803, 2022 04.

Article in English | MEDLINE | ID: covidwho-1705182

Subject(s)

Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized/therapeutic use; Antibodies, Neutralizing; Humans; Kidney

Keywords

COVID-19; Omicron; monoclonal antibodies; organ transplantation; prevention

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Topics: Vaccines / Variants Limits: Humans Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Tid.13803

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google